AGP Executive Report
Last update: 9 hours agoDrug Pricing Push: TrumpRx is adding 600+ generic drugs via deals with Amazon Pharmacy, GoodRx, and Mark Cuban’s Cost Plus, aiming to steer patients to lower-cost options and expand beyond brand-heavy listings. Sleep Tech: Sunrise won FDA clearance for Sunrise Air, a next-gen at-home sleep apnea test that adds airflow, oxygen, pulse, and snoring analysis to better separate obstructive vs central cases. Stroke Pipeline: FDA accepted Bayer’s asundexian for priority review in secondary stroke prevention after non-cardioembolic stroke/TIA, following phase 3 OCEANIC-STROKE results. Care Access Reality Check: A survey finds clinicians often lack visibility into what happens after e-prescriptions are sent—patients may not fill meds, and the gap drives delays and extra admin work. Policy & Politics: California’s health care pay cap initiative cleared signature thresholds for the November ballot, targeting executive compensation above $450,000 (with public hospitals exempt). Animal Health: FDA issued an EUA for doramectin to prevent/treat New World screwworm in multiple livestock species.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.